Julie Olsson

1.8k citations
15 papers · 1.1k indexed · 1 hit paper · h-index 11

Julie Olsson

15 papers receiving 1.1k citations

Hit Papers

Efficacy and safety of lebrikizumab in patients with unco...20162026201920222016100200300

Peers

Julie Olsson
Comparison fields: 5 of 80
  • Pulmonary and Respiratory Medicine 597
  • Physiology 589
  • Immunology 286
  • Immunology and Allergy 212
  • Oncology 179
Replace May Mo with:
May Mo United States
Brian D. Modena United States
Necdet B. Gunsoy United Kingdom
JingYuan Feng United States
Patricia Rohane United States
Gun Almqvist Sweden
Natasha Purington United States
Lynn E. Katz United States
J. Thirlwell United Kingdom
Katerina Samara Greece
Julie Olsson relative to May Mo United States May Mo's profile →
Citations per field
00.5×5.5×
May Mo · 1×
Citations per year

Countries citing papers authored by Julie Olsson

Since Specialization
Citations

This map shows the geographic impact of Julie Olsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Olsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Olsson more than expected).

Fields of papers citing papers by Julie Olsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Olsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Olsson. The network helps show where Julie Olsson may publish in the future.

Co-authorship network of co-authors of Julie Olsson

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Olsson. A scholar is included among the top collaborators of Julie Olsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Olsson. Julie Olsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 2
2 4
3 51
4 6
5 16
6 46
7 16
8
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trialsbreakdown →
350
9 1
10 299
11 21
12 153
13 42
14 67
15 10

About Julie Olsson

Julie Olsson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pharmacy, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (7 papers), Respiratory and Cough-Related Research (5 papers) and IL-33, ST2, and ILC Pathways (4 papers). The work is most often cited by research in Immunology and Allergy (212 citations), Physiology (589 citations) and Pulmonary and Respiratory Medicine (597 citations). Julie Olsson has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Michael K. Gould, Cécile Holweg, John G. Matthews, Wendy S. Putnam, Nicola A. Hanania, Sarah Gray, Phillip E. Korenblat, Saloumeh K Fischer, Kun Peng and Akihito Yokoyama. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and European Respiratory Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026